ReP USP - Resultado da busca

Filtros : "Pinero, Federico" Limpar

Filtros

Artigo de periodico
Performance of pre-transplant criteria in prediction of hepatocellular carcinoma progression and waitlist dropout (2022)
Pinero, Federico; Thompson, Marcos; Boin, Ilka; Chagas, Aline; Quinonez, Emilio; Bermudez, Carla; Vilatoba, Mario; Santos, Luisa; Anders, Margarita; Duque, Sergio Hoyos; Carrilho, Flair Jose
Source: Liver international. Unidade: FM
Subjects: CARCINOMA HEPATOCELULAR, RECIDIVA, CUIDADOS PRÉ-OPERATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINERO, Federico et al. Performance of pre-transplant criteria in prediction of hepatocellular carcinoma progression and waitlist dropout. Liver international, v. 42, n. 8, p. 1879-1890, 2022Tradução . . Disponível em: https://doi.org/10.1111/liv.15223. Acesso em: 08 nov. 2024.
APA
Pinero, F., Thompson, M., Boin, I., Chagas, A., Quinonez, E., Bermudez, C., et al. (2022). Performance of pre-transplant criteria in prediction of hepatocellular carcinoma progression and waitlist dropout. Liver international, 42( 8), 1879-1890. doi:10.1111/liv.15223
NLM
Pinero F, Thompson M, Boin I, Chagas A, Quinonez E, Bermudez C, Vilatoba M, Santos L, Anders M, Duque SH, Carrilho FJ. Performance of pre-transplant criteria in prediction of hepatocellular carcinoma progression and waitlist dropout [Internet]. Liver international. 2022 ; 42( 8): 1879-1890.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1111/liv.15223
Vancouver
Pinero F, Thompson M, Boin I, Chagas A, Quinonez E, Bermudez C, Vilatoba M, Santos L, Anders M, Duque SH, Carrilho FJ. Performance of pre-transplant criteria in prediction of hepatocellular carcinoma progression and waitlist dropout [Internet]. Liver international. 2022 ; 42( 8): 1879-1890.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1111/liv.15223
Artigo de periodico
Direct-acting antivirals and hepatocellular carcinoma: no evidence of higher wait-List progression or posttransplant recurrence (2020)
Pinero, Federico; Boin, Ilka; Chagas, Aline; Quinonez, Emilio; Marciano, Sebastian; Vilatoba, Mario; Santos, Luisa; Anders, Margarita; Duque, Sergio Hoyos; Carrilho, Flair Jose
Source: Liver transplantation. Unidade: FM
Subjects: ANTIVIRAIS, HEPATITE, TRANSPLANTE DE FÍGADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINERO, Federico et al. Direct-acting antivirals and hepatocellular carcinoma: no evidence of higher wait-List progression or posttransplant recurrence. Liver transplantation, v. 26, n. 5, p. 640-650, 2020Tradução . . Disponível em: https://doi.org/10.1002/lt.25744. Acesso em: 08 nov. 2024.
APA
Pinero, F., Boin, I., Chagas, A., Quinonez, E., Marciano, S., Vilatoba, M., et al. (2020). Direct-acting antivirals and hepatocellular carcinoma: no evidence of higher wait-List progression or posttransplant recurrence. Liver transplantation, 26( 5), 640-650. doi:10.1002/lt.25744
NLM
Pinero F, Boin I, Chagas A, Quinonez E, Marciano S, Vilatoba M, Santos L, Anders M, Duque SH, Carrilho FJ. Direct-acting antivirals and hepatocellular carcinoma: no evidence of higher wait-List progression or posttransplant recurrence [Internet]. Liver transplantation. 2020 ; 26( 5): 640-650.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1002/lt.25744
Vancouver
Pinero F, Boin I, Chagas A, Quinonez E, Marciano S, Vilatoba M, Santos L, Anders M, Duque SH, Carrilho FJ. Direct-acting antivirals and hepatocellular carcinoma: no evidence of higher wait-List progression or posttransplant recurrence [Internet]. Liver transplantation. 2020 ; 26( 5): 640-650.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1002/lt.25744

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024